Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugene A Woltering

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Angiogenesis|January 24, 2004
Inhibition of angiogenic initiation and disruption of newly established human vascular networks by juice from Morinda citrifolia (noni)Conrad A Hornick, Amy Myers, Halina Sadowska-Krowicka, et al.
Pancreas|November 20, 2012
A single fasting plasma 5-HIAA value correlates with 24-hour urinary 5-HIAA values and other biomarkers in midgut neuroendocrine tumors (NETs)Maria R Tellez, Gregg Mamikunian, Thomas M O'Dorisio, et al.
Journal of Agricultural and Food Chemistry|May 12, 2005
Black raspberry extract and fractions contain angiogenesis inhibitorsZhijun Liu, Joshua Schwimer, Dong Liu, et al.
Surgery|December 5, 2009
Lymphatic mapping helps to define resection margins for midgut carcinoidsYi-Zarn Wang, Saju Joseph, Erika Lindholm, et al.
Annals of Surgical Oncology|July 22, 2020
Management of Appendiceal Neuroendocrine Tumors: Metastatic Potential of Small TumorsJace P Landry, Brianne A Voros, Robert A Ramirez, et al.
Journal of the American College of Surgeons|April 24, 2012
Cervical and upper mediastinal lymph node metastasis from gastrointestinal and pancreatic neuroendocrine tumors: true incidence and managementYi-Zarn Wang, George Mayhall, Lowell B Anthony, et al.
The Journal of Surgical Research|February 21, 2012
Do primary neuroendocrine tumors and metastasis have the same characteristics?Erika B Lindholm, John Lyons, Catherine T Anthony, et al.
The Oncologist|May 27, 2016
The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine TumorsRobert A Ramirez, David T Beyer, Aman Chauhan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 4, 2006
In vitro modeling of the clinical interactions between octreotide and 111In-pentetreotide: is there evidence of somatostatin receptor downregulation?Susan H Gunn, Joshua E Schwimer, Mary Cox, et al.
Pancreas|March 31, 2012
A prospective evaluation of the effect of chronic proton pump inhibitor use on plasma biomarker levels in humansDaniel Raines, Maria Chester, Anne E Diebold, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Angiogenesis|January 24, 2004
Inhibition of angiogenic initiation and disruption of newly established human vascular networks by juice from Morinda citrifolia (noni)Conrad A Hornick, Amy Myers, Halina Sadowska-Krowicka, et al.
Pancreas|November 20, 2012
A single fasting plasma 5-HIAA value correlates with 24-hour urinary 5-HIAA values and other biomarkers in midgut neuroendocrine tumors (NETs)Maria R Tellez, Gregg Mamikunian, Thomas M O'Dorisio, et al.
Journal of Agricultural and Food Chemistry|May 12, 2005
Black raspberry extract and fractions contain angiogenesis inhibitorsZhijun Liu, Joshua Schwimer, Dong Liu, et al.
Surgery|December 5, 2009
Lymphatic mapping helps to define resection margins for midgut carcinoidsYi-Zarn Wang, Saju Joseph, Erika Lindholm, et al.
Annals of Surgical Oncology|July 22, 2020
Management of Appendiceal Neuroendocrine Tumors: Metastatic Potential of Small TumorsJace P Landry, Brianne A Voros, Robert A Ramirez, et al.
Journal of the American College of Surgeons|April 24, 2012
Cervical and upper mediastinal lymph node metastasis from gastrointestinal and pancreatic neuroendocrine tumors: true incidence and managementYi-Zarn Wang, George Mayhall, Lowell B Anthony, et al.
The Journal of Surgical Research|February 21, 2012
Do primary neuroendocrine tumors and metastasis have the same characteristics?Erika B Lindholm, John Lyons, Catherine T Anthony, et al.
The Oncologist|May 27, 2016
The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine TumorsRobert A Ramirez, David T Beyer, Aman Chauhan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 4, 2006
In vitro modeling of the clinical interactions between octreotide and 111In-pentetreotide: is there evidence of somatostatin receptor downregulation?Susan H Gunn, Joshua E Schwimer, Mary Cox, et al.
Pancreas|March 31, 2012
A prospective evaluation of the effect of chronic proton pump inhibitor use on plasma biomarker levels in humansDaniel Raines, Maria Chester, Anne E Diebold, et al.
Pageof 7